Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT05428605
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 18 years
2. Patient with MN proven on renal biopsy or by the presence of anti-PLA2R1 or anti-THDS71 antibodies
3. Relapsed MN, defined as proteinuria \> 3.5g/g after achieving remission (partial or complete, definitions according to KDIGO 2012 guidelines)
4. At a distance from any immunosuppressive treatment (at least 6 months)
5. Freely given informed consent signed by the patient after clear, fair and appropriate information
6. Affiliated to a social security system
Exclusion Criteria:
1. Pregnant or breastfeeding woman
2. Patient under 18 years of age
3. Persons of legal age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05428605
Study Brief:
Protocol Section:
NCT05428605